By Kiku Steinfeld
Chicago, Jan. 5 – Morgan Stanley Finance LLC priced $640,000 of contingent income autocallable securities due Jan. 4, 2024 linked to the worse performing of the Technology Select Sector SPDR fund and the SPDR S&P Biotech exchange-traded fund, according to a 424B2 filing with the Securities and Exchange Commission.
The notes will pay a contingent quarterly coupon at an annual rate of 9% if each ETF closes at or above its 75% downside threshold on the determination date that quarter.
The notes will be called at par plus the contingent coupon if each ETF closes at or above its initial level on any quarterly determination date other than the final determination date.
The payout at maturity will be par plus the contingent coupon unless either ETF finishes below its 75% downside threshold, in which case investors will lose 1% for each 1% decline of the lesser performing ETF.
The notes are guaranteed by Morgan Stanley.
Morgan Stanley & Co. LLC is the agent.
| Issuer: | Morgan Stanley Finance LLC
|
| Guarantor: | Morgan Stanley
|
| Issue: | Contingent income autocallable securities
|
| Amount: | $640,000
|
| Underlying ETFs: | Technology Select Sector SPDR fund and SPDR S&P Biotech ETF
|
| Maturity: | Jan. 4, 2024
|
| Coupon: | 9% annualized for each quarter that each ETF closes at or above downside threshold on observation date for quarter
|
| Price: | Par
|
| Payout at maturity: | Par plus contingent coupon if each ETF finishes at or above downside threshold; otherwise, 1% loss for each 1% decline of worst performing ETF
|
| Call: | At par plus contingent payment if each ETF closes at or above initial level on any quarterly determination date other than the final determination date
|
| Initial levels: | $129.90 for Technology Select, $142.17 for Biotech
|
| Downside thresholds: | $97.425 for Technology Select, $106.62 for S&P Biotech; 75% of initial levels
|
| Pricing date: | Dec. 29
|
| Settlement date: | Dec. 31
|
| Agent: | Morgan Stanley & Co. LLC
|
| Fees: | 1.9%
|
| Cusip: | 61771EWH7
|
|
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
